Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.41 |
| ▸ | OTC | P00480 | 1/20 | 0.37 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.36 |
| ▸ | RRM1 | P23921 | 1/20 | 0.35 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 2/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.33 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17995247 | 1.00 | DPP7 (0.41) | DPP7OTCGNAI3GNAO1GNAI1 | |
| Tilarginine SCHEMBL1321022 | 0.87 | OTC (0.49) | DPP7OTCDDAH1NOS3NOS1 | |
| Tilarginine SCHEMBL6370536 | 0.86 | OTC (0.51) | DPP7OTCDDAH1NOS3NOS1 | |
| SCHEMBL19608041 | 0.86 | DPP7 (0.41) | DPP7OTCGNAI3GNAO1GNAI1 | |
| Tilarginine SCHEMBL12028766 | 0.86 | OTC (0.51) | DPP7OTCDDAH1NOS3NOS1 | |
| Tilarginine SCHEMBL315843 | 0.86 | OTC (0.51) | DPP7OTCDDAH1NOS3NOS1 | |
| Tilarginine SCHEMBL2229626 | 0.85 | OTC (0.50) | DPP7OTCDDAH1NOS3NOS1 | |
| SCHEMBL18542868 | 0.84 | DPP7 (0.44) | DPP7OTCGNAI3GNAO1GNAI1 | |
| SCHEMBL18542869 | 0.84 | DPP7 (0.44) | DPP7OTCGNAI3GNAO1GNAI1 | |
| SCHEMBL19368710 | 0.84 | DPP7 (0.44) | DPP7OTCGNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3311823-B1 | METHODS AND COMPOSITIONS FOR DISRUPTING BIOFILM UTILIZING CHITOSAN-DERIVATIVE COMPOUNDS | SYNEDGEN INC (US) | 2020-11-25 | — | — | EP | disclosed |
| EP-2555760-B1 | CHITOSAN DERIVATIVES FOR THE TREATMENT OF MUCOSITIS OR ULCERATION | SYNEDGEN INC (US) | 2019-10-16 | — | — | EP | disclosed |
| US-20130190227-A1 | CHITOSAN DERIVATIVES TO TREAT ANIMALS OR OPTIMIZE ANIMAL HEALTH | SYNEDGEN, INC. (US) | 2013-07-25 | — | — | US | disclosed |
| WO-2011127144-A1 | METHODS AND COMPOSITIONS FOR TREATING WOUNDS UTILIZING CHITOSAN COMPOUNDS | SYNEDGEN INC. (US) | 2011-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130190227-A1 | CHITOSAN DERIVATIVES TO TREAT ANIMALS OR OPTIMIZE ANIMAL HEALTH | CHIT1, CHIA, ALG1 | DPP7 461/4885OTC 428/4885GNAI3 3171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.